Nursing and Health Professions
Pioglitazone
100%
Nonalcoholic Fatty Liver
62%
Placebo
50%
Inpatient
50%
Body Fat
50%
Total Body Water
50%
Body Weight Gain
37%
Procedures
25%
Water
25%
Impaired Glucose Tolerance
12%
Body Weight
12%
Insulin Resistance
12%
Chronic Liver Disease
12%
Blindness
12%
Medicine and Dentistry
Pioglitazone
100%
Patient
75%
Nonalcoholic Fatty Liver
62%
Therapeutic Procedure
62%
Body Fat
50%
Maturity Onset Diabetes of the Young
25%
Water
25%
Body Weight
12%
Impaired Glucose Tolerance
12%
Insulin Resistance
12%
Chronic Liver Disease
12%
Water Retention
12%
Muscle
12%
Adipose Tissue
12%
Amaurosis
12%
Biochemistry, Genetics and Molecular Biology
Pioglitazone
100%
Body Fat
50%
Total Body Water
50%
Weight
37%
Body Weight
12%
Dilution
12%
Insulin Resistance
12%
Hydration
12%
Impaired Glucose Tolerance
12%
Water Retention
12%
Pharmacology, Toxicology and Pharmaceutical Science
Pioglitazone
100%
Nonalcoholic Fatty Liver
62%
Non Insulin Dependent Diabetes Mellitus
25%
Water
25%
Insulin Resistance
12%
Hydration
12%
Impaired Glucose Tolerance
12%
Chronic Liver Disease
12%
Blindness
12%
Neuroscience
Pioglitazone
100%
Dual-Energy X-Ray Absorptiometry
50%
Placebo
50%
Diabetes Mellitus
25%
Adipose Tissue
12%